Ask us about our cell and gene therapy products, including both research and clinical use Discovery Leukopaks.

Discovery Life Sciences are the Biospecimen & Biomarker Specialists™. We have the world’s largest biospecimen inventory and procurement network with preeminent multi-omic service laboratories to accelerate precision medicine programs in oncology, immuno-oncology, immunology, inflammation, infectious diseases, and beyond. We are pleased to announce ReachBio is now a part of Discovery Life Sciences.

Our biobanks include more than 10 million biospecimens and we have hundreds of clinical sites (Discovery Partners®) that allow researchers to build bespoke study cohorts and seamlessly interrogate them using our CLIA certified, GLP-compliant service laboratories, including our world-renowned Genomic Sequencing and bioinformatics laboratory, HudsonAlpha Discovery, our expert IHC services laboratory that developed the pembrolizumab PD-L1 IHC companion diagnostic prototype, our Proteomic Services labs that offer Olink, Luminex, Seer Proteograph and Mass Spec protein profiling, and our Cell Biology laboratory provides extensive Flow cytometry and single cell RNASeq services with GMP-compliant leukapheresis products for cell therapy development and manufacturing. We also offer clinical flow cytometry services for analysis of trial samples.

We are committed to quality and integrity with ISO 13485, GMP- and GCLP-compliant and CLIA-certified labs, stringent IRB and Ethics Committee compliance, and all required approvals and certifications. Navigating US and international personal data protection, drug development and diagnostic development regulations is one of our core competencies. AllCells is the CGT brand of Discovery Life Sciences